Active Ingredient: TERLIPRESSIN ACETATE
Proprietary Name: TERLIVAZ
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 0.85MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N022231
Product Number: 001
Approval Date: Sep 14, 2022
Applicant Holder Full Name: MALLINCKRODT PHARMACEUTICALS IRELAND LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
